QUETIAPINE FUMARATE 25 MG TAB
For 30 tablets
Pharmacies pay
$0.64 filed
30 × $0.02147 per EA
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D paid
$9.44 filed
30 × $0.31465 per EA, Part D average
Medicare's price is not your price.
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
The spread
14.7× estimated
Medicare paid 14.7× what pharmacies pay.
Part D averages every strength and form sold under “Quetiapine Fumarate” into one figure, so it is not specific to this NDC.
OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)
Cost-plus estimate
$5.74 estimated
$0.64 + $0.10 (15%) + $5.00 fee per fill = $5.74
This is a model, not a price any pharmacy quoted. Shipping is not included. For a pack this cheap, the $5.00 fee is most of the estimate. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
QUETIAPINE FUMARATE 25 MG TAB is how the CMS NADAC file names this product. The FDA NDC Directory lists it as “quetiapine” and “quetiapine fumarate”, as its NDCs’ listings variously write the nonproprietary name.
FDA gives its dosage form as “tablet, film coated” and “tablet” and its route as oral.
FDA lists 14 labelers (the companies named on the label) for its NDCs, among them Teva Pharmaceuticals USA, Inc., Major Pharmaceuticals and Rising Pharma Holdings, Inc.
FDA’s Established Pharmacologic Class for it is Atypical Antipsychotic.
The NADAC file of 2026-10-14 prices it under 23 NDCs (National Drug Codes); the FDA directory lists 21 of them.
NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.
What pharmacies pay
Pharmacies pay $0.64 for 30 tablets (30 × $0.02147 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.
What NADAC measures · Why 30 tablets · NADAC explanation codes
The 14 labelers
| Labeler | NDCs | Pharmacies pay per unit |
|---|---|---|
| Ascend Laboratories, LLC | 2 | $0.02147 per EA filed |
| BluePoint Laboratories | 2 | $0.02147 per EA filed |
| Lupin Pharmaceuticals, Inc. | 2 | $0.02147 per EA filed |
| NorthStar Rx LLC | 2 | $0.02147 per EA filed |
| Rising Pharma Holdings, Inc. | 2 | $0.02147 per EA filed |
| Solco Healthcare US, LLC | 2 | $0.02147 per EA filed |
| Unichem Pharmaceuticals (USA), Inc. | 2 | $0.02147 per EA filed |
| American Health Packaging | 1 | $0.02147 per EA filed |
| Aurobindo Pharma Limited | 1 | $0.02147 per EA filed |
| AvPAK | 1 | $0.02147 per EA filed |
| Camber Pharmaceuticals, Inc. | 1 | $0.02147 per EA filed |
| Major Pharmaceuticals | 1 | $0.02147 per EA filed |
| Quallent Pharmaceuticals Health LLC | 1 | $0.02147 per EA filed |
| Teva Pharmaceuticals USA, Inc. | 1 | $0.02147 per EA filed |
| Not listed as a package in the FDA directory | 2 | $0.02147 per EA filed |
All 23 NDCs, with labeler and price
- 00093-2063-01 · Teva Pharmaceuticals USA, Inc. · $0.02147 per EA · eff. 2026-09-23 filed
- 00904-6638-61 · Major Pharmaceuticals · $0.02147 per EA · eff. 2026-09-23 filed
- 16571-0717-01 · Rising Pharma Holdings, Inc. · $0.02147 per EA · eff. 2026-09-23 filed
- 16571-0717-10 · Rising Pharma Holdings, Inc. · $0.02147 per EA · eff. 2026-09-23 filed
- 16714-0375-01 · NorthStar Rx LLC · $0.02147 per EA · eff. 2026-09-23 filed
- 16714-0375-02 · NorthStar Rx LLC · $0.02147 per EA · eff. 2026-09-23 filed
- 29300-0147-01 · Unichem Pharmaceuticals (USA), Inc. · $0.02147 per EA · eff. 2026-09-23 filed
- 29300-0147-10 · Unichem Pharmaceuticals (USA), Inc. · $0.02147 per EA · eff. 2026-09-23 filed
- 31722-0764-01 · Camber Pharmaceuticals, Inc. · $0.02147 per EA · eff. 2026-09-23 filed
- 43547-0518-10 · Solco Healthcare US, LLC · $0.02147 per EA · eff. 2026-09-23 filed
- 43547-0518-11 · Solco Healthcare US, LLC · $0.02147 per EA · eff. 2026-09-23 filed
- 50268-0630-11 · not listed as a package in the FDA directory · $0.02147 per EA · eff. 2026-09-23 filed
- 50268-0630-15 · AvPAK · $0.02147 per EA · eff. 2026-09-23 filed
- 60687-0327-01 · American Health Packaging · $0.02147 per EA · eff. 2026-09-23 filed
- 60687-0327-11 · not listed as a package in the FDA directory · $0.02147 per EA · eff. 2026-09-23 filed
- 65862-0489-01 · Aurobindo Pharma Limited · $0.02147 per EA · eff. 2026-09-23 filed
- 67877-0242-01 · Ascend Laboratories, LLC · $0.02147 per EA · eff. 2026-09-23 filed
- 67877-0242-10 · Ascend Laboratories, LLC · $0.02147 per EA · eff. 2026-09-23 filed
- 68001-0185-00 · BluePoint Laboratories · $0.02147 per EA · eff. 2026-09-23 filed
- 68001-0185-08 · BluePoint Laboratories · $0.02147 per EA · eff. 2026-09-23 filed
- 68180-0445-01 · Lupin Pharmaceuticals, Inc. · $0.02147 per EA · eff. 2026-09-23 filed
- 68180-0445-03 · Lupin Pharmaceuticals, Inc. · $0.02147 per EA · eff. 2026-09-23 filed
- 82009-0095-01 · Quallent Pharmaceuticals Health LLC · $0.02147 per EA · eff. 2026-09-23 filed
Other strengths, forms and brands
12 other products in the NADAC file share an FDA nonproprietary name with QUETIAPINE FUMARATE 25 MG TAB.
| Product | Pharmacies pay per unit | Medicare per unit |
|---|---|---|
| QUETIAPINE 150 MG TABLET | $1.23864 per EA filed | $0.31465 per EA filed |
| QUETIAPINE ER 50 MG TABLET | $0.11917 per EA filed | $1.3832 per EA filed |
| QUETIAPINE ER 150 MG TABLET | $0.18361 per EA filed | $1.3832 per EA filed |
| QUETIAPINE ER 200 MG TABLET | $0.21991 per EA filed | $1.3832 per EA filed |
| QUETIAPINE ER 300 MG TABLET | $0.27174 per EA filed | $1.3832 per EA filed |
| QUETIAPINE ER 400 MG TABLET | $0.31743 per EA filed | $1.3832 per EA filed |
| QUETIAPINE FUMARATE 25 MG TAB this page | $0.02147 per EA filed | $0.31465 per EA filed |
| QUETIAPINE FUMARATE 50 MG TAB | $0.02817 per EA filed | $0.31465 per EA filed |
| QUETIAPINE FUMARATE 100 MG TAB | $0.0483 per EA filed | $0.31465 per EA filed |
| QUETIAPINE FUMARATE 200 MG TAB | $0.08962 per EA filed | $0.31465 per EA filed |
| QUETIAPINE FUMARATE 300 MG TAB | $0.12747 per EA filed | $0.31465 per EA filed |
| QUETIAPINE FUMARATE 400 MG TAB | $0.16163 per EA filed | $0.31465 per EA filed |
| SEROQUEL XR 400 MG TABLET | $26.35797 per EA filed | $18.8754 per EA filed |
Part D is one average per brand and generic name, over every strength and form.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
Compared with its class
The middle of its 23 NDCs’ NADAC prices is $0.02147 per EA filed.
Of the 130 other products in FDA’s Atypical Antipsychotic class priced per EA, 130 have a higher middle NADAC price and 0 a lower one. The one in the middle is CLOZAPINE ODT 100 MG TABLET, at $4.26464 per EA filed (eff. 2026-09-23).
Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
What Medicare paid
Medicare Part D paid $9.44 for 30 tablets, at an average of $0.31465 per EA in 2024 (2024-01-01 to 2024-12-31) for “Quetiapine Fumarate”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).
That average covers 9,340,374 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.
Medicare's price is not your price.
What Part D spending measures · Which Medicare figure OpenBill compares · How the spread is worked out
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 30 tablets? Is it lower than what I would pay through my insurance?
- If you have Medicare Part D: what is my plan’s copay or coinsurance for it? The Part D average on this page is not what you pay.
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.
Questions
- Why is the comparison with Medicare for QUETIAPINE FUMARATE 25 MG TAB labelled estimated?
- Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Quetiapine Fumarate / Quetiapine Fumarate: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name.
Related pages
Its pharmacologic class
Related in the same class
- ARIPIPRAZOLE 10 MG TABLET
- OLANZAPINE 10 MG TABLET
- RISPERIDONE 0.25 MG TABLET
- CLOZAPINE 100 MG TABLET
- LURASIDONE HCL 120 MG TABLET